Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized study of napabucasin plus best supportive care versus placebo plus best supportive care in pretreated advanced colorectal cancer
jRCT2080222249Phase 3
- Sponsor
- Sumitomo Pharma
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colorectal cancer (CRC) comparing Napabucasin + best supportive care with Placebo + best supportive care (2 arms).
02
Drugs
napabucasin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCT2080222249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222249.